Safety of patients must remain at the heart of medicine importation

Kenya's Ministry of Health halted unregulated parallel importation of medicines to strengthen the pharmaceutical regulatory system. Critics warn that medicines require strict oversight from manufacturing to post-market surveillance. Kenya is pursuing the WHO's Maturity Level 3 and plans a serialization system to track products. Implementing the 2019 parallel importation framework is key to ensuring safety and quality.